As part of the ClearView Healthcare Partners leadership team, Philip works with clients to support decision-making and pursue strategic growth. His project experience includes all major therapeutic areas, providing broad perspective on opportunities for biopharmaceutical innovation.
Philip has 10 years of experience in biopharmaceutical-related research and consulting, and believes that strategy in the life sciences space requires a combination of scientific and clinical understanding paired with a strategic commercial perspective. He and his project teams work with clients to identify expected evolution in clinical paradigms, future competition, and reimbursement and regulatory dynamics to optimize decision-making across all phases of development and commercialization.
Philip earned his B.A. in biochemical sciences from Harvard University and received his M.Sc. in molecular medicine from University College London.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson